Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 90
Selected: 0
NCT IDTitle
NCT02188277Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
NCT05585398A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods
NCT00804271Memantine and Validation of a New Alzheimer's Disease Scale
NCT00649220Memantine and Antipsychotics Use
NCT02207946Botulinum Toxin A to Treat Arm Tremor
NCT00429520Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds
NCT01109680A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects
NCT06091020A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
NCT01405482Botulinum Toxin Injections for Thoracic Outlet Syndrome
NCT04594213Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT02462317Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
NCT07018713A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
NCT01603459Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01905683Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
NCT00465738IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
NCT00909883Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)
NCT03256942Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation
NCT00432666IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb
NCT00773591Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders
NCT07018700A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
NCT01893411Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
NCT05884528Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
NCT00405886Neramexane for Tinnitus
NCT02270736Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT00770029IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
NCT00694148Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT05943860Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss
NCT04210258Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
NCT00712283Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers
NCT00430586Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
NCT00972127Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT00955760Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate
NCT00772980Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
NCT00406367IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
NCT02002884Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
NCT03119948Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
NCT00515944Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
NCT07486830IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction
NCT04908423Xeomin® and Gait Related Mobility After Stroke
NCT01098019Treatment of Notalgia Paresthetica With Xeomin
NCT02091739Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions
NCT04792398Bruxism Xeomin® Intervention Trial
NCT01896895Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
NCT00430963IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT00983099Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects
NCT00624026Memantine - Communication Study
NCT01305187Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3
NCT00507637Blepharospasm Short Interval
NCT00739635Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT01910896Effectiveness and Safety Study of Overnight Intensive Patch in Scars